Protalix

Showing 1 posts of 1 posts found.

Nerve gas antidote completes phase I trial

June 9, 2010
Research and Development Protalix, biodefence

Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …

The Gateway to Local Adoption Series

Latest content